245 related articles for article (PubMed ID: 29455155)
1. Newly designed 11-gene panel reveals first case of hereditary amyloidosis captured by massive parallel sequencing.
Chyra Kufova Z; Sevcikova T; Januska J; Vojta P; Boday A; Vanickova P; Filipova J; Growkova K; Jelinek T; Hajduch M; Hajek R
J Clin Pathol; 2018 Aug; 71(8):687-694. PubMed ID: 29455155
[TBL] [Abstract][Full Text] [Related]
2. A new genetic variant of hereditary apolipoprotein A-I amyloidosis: a case-report followed by discussion of diagnostic challenges and therapeutic options.
Moutafi M; Ziogas DC; Michopoulos S; Bagratuni T; Vasileiou V; Verga L; Merlini G; Palladini G; Matsouka C; Dimopoulos MA; Kastritis E
BMC Med Genet; 2019 Jan; 20(1):23. PubMed ID: 30665372
[TBL] [Abstract][Full Text] [Related]
3. TumorNext: A comprehensive tumor profiling assay that incorporates high resolution copy number analysis and germline status to improve testing accuracy.
Gray PN; Vuong H; Tsai P; Lu HM; Mu W; Hsuan V; Hoo J; Shah S; Uyeda L; Fox S; Patel H; Janicek M; Brown S; Dobrea L; Wagman L; Plimack E; Mehra R; Golemis EA; Bilusic M; Zibelman M; Elliott A
Oncotarget; 2016 Oct; 7(42):68206-68228. PubMed ID: 27626691
[TBL] [Abstract][Full Text] [Related]
4. Novel Phenotype-Genotype Correlations of Restrictive Cardiomyopathy With Myosin-Binding Protein C (MYBPC3) Gene Mutations Tested by Next-Generation Sequencing.
Wu W; Lu CX; Wang YN; Liu F; Chen W; Liu YT; Han YC; Cao J; Zhang SY; Zhang X
J Am Heart Assoc; 2015 Jul; 4(7):. PubMed ID: 26163040
[TBL] [Abstract][Full Text] [Related]
5. Clinical evaluation of panel testing by next-generation sequencing (NGS) for gene mutations in myeloid neoplasms.
Au CH; Wa A; Ho DN; Chan TL; Ma ES
Diagn Pathol; 2016 Jan; 11():11. PubMed ID: 26796102
[TBL] [Abstract][Full Text] [Related]
6. Development and analytical validation of a 25-gene next generation sequencing panel that includes the BRCA1 and BRCA2 genes to assess hereditary cancer risk.
Judkins T; Leclair B; Bowles K; Gutin N; Trost J; McCulloch J; Bhatnagar S; Murray A; Craft J; Wardell B; Bastian M; Mitchell J; Chen J; Tran T; Williams D; Potter J; Jammulapati S; Perry M; Morris B; Roa B; Timms K
BMC Cancer; 2015 Apr; 15():215. PubMed ID: 25886519
[TBL] [Abstract][Full Text] [Related]
7. Mutational profiling in the peripheral blood leukocytes of patients with systemic mast cell activation syndrome using next-generation sequencing.
Altmüller J; Haenisch B; Kawalia A; Menzen M; Nöthen MM; Fier H; Molderings GJ
Immunogenetics; 2017 Jun; 69(6):359-369. PubMed ID: 28386644
[TBL] [Abstract][Full Text] [Related]
8. The long tail of molecular alterations in non-small cell lung cancer: a single-institution experience of next-generation sequencing in clinical molecular diagnostics.
Fumagalli C; Vacirca D; Rappa A; Passaro A; Guarize J; Rafaniello Raviele P; de Marinis F; Spaggiari L; Casadio C; Viale G; Barberis M; Guerini-Rocco E
J Clin Pathol; 2018 Sep; 71(9):767-773. PubMed ID: 29535211
[TBL] [Abstract][Full Text] [Related]
9. Amyloid heart disease mimicking hypertrophic cardiomyopathy.
Mörner S; Hellman U; Suhr OB; Kazzam E; Waldenström A
J Intern Med; 2005 Sep; 258(3):225-30. PubMed ID: 16115295
[TBL] [Abstract][Full Text] [Related]
10. Identification of a Variety of Mutations in Cancer Predisposition Genes in Patients With Suspected Lynch Syndrome.
Yurgelun MB; Allen B; Kaldate RR; Bowles KR; Judkins T; Kaushik P; Roa BB; Wenstrup RJ; Hartman AR; Syngal S
Gastroenterology; 2015 Sep; 149(3):604-13.e20. PubMed ID: 25980754
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive genetic testing approach for major inherited kidney diseases, using next-generation sequencing with a custom panel.
Mori T; Hosomichi K; Chiga M; Mandai S; Nakaoka H; Sohara E; Okado T; Rai T; Sasaki S; Inoue I; Uchida S
Clin Exp Nephrol; 2017 Feb; 21(1):63-75. PubMed ID: 26920127
[TBL] [Abstract][Full Text] [Related]
12. Validation of CZECANCA (CZEch CAncer paNel for Clinical Application) for targeted NGS-based analysis of hereditary cancer syndromes.
Soukupova J; Zemankova P; Lhotova K; Janatova M; Borecka M; Stolarova L; Lhota F; Foretova L; Machackova E; Stranecky V; Tavandzis S; Kleiblova P; Vocka M; Hartmannova H; Hodanova K; Kmoch S; Kleibl Z
PLoS One; 2018; 13(4):e0195761. PubMed ID: 29649263
[TBL] [Abstract][Full Text] [Related]
13. Analysis of selected genes associated with cardiomyopathy by next-generation sequencing.
Szabadosova V; Boronova I; Ferenc P; Tothova I; Bernasovska J; Zigova M; Kmec J; Bernasovsky I
J Clin Lab Anal; 2018 Feb; 32(2):. PubMed ID: 28594148
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein genetic variants and hereditary amyloidosis.
Jeraj N; Hegele RA; Berberich AJ
Curr Opin Lipidol; 2021 Apr; 32(2):132-140. PubMed ID: 33395107
[TBL] [Abstract][Full Text] [Related]
15. Multiplexed Reference Materials as Controls for Diagnostic Next-Generation Sequencing: A Pilot Investigating Applications for Hypertrophic Cardiomyopathy.
Kudalkar EM; Almontashiri NA; Huang C; Anekella B; Bowser M; Hynes E; Garlick R; Funke BH
J Mol Diagn; 2016 Nov; 18(6):882-889. PubMed ID: 27639548
[TBL] [Abstract][Full Text] [Related]
16. Targeted next-generation sequencing (NGS) of nine candidate genes with custom AmpliSeq in patients and a cardiomyopathy risk group.
Glotov AS; Kazakov SV; Zhukova EA; Alexandrov AV; Glotov OS; Pakin VS; Danilova MM; Poliakova IV; Niyazova SS; Chakova NN; Komissarova SM; Kurnikova EA; Sarana AM; Sherbak SG; Sergushichev AA; Shalyto AA; Baranov VS
Clin Chim Acta; 2015 Jun; 446():132-40. PubMed ID: 25892673
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of germline mutations in the TTR gene in a consecutive series of surgical pathology specimens with ATTR amyloid.
Eriksson M; Büttner J; Todorov T; Yumlu S; Schönland S; Hegenbart U; Kristen AV; Dengler T; Lohse P; Helmke B; Schmidt H; Röcken C
Am J Surg Pathol; 2009 Jan; 33(1):58-65. PubMed ID: 18830126
[TBL] [Abstract][Full Text] [Related]
18. Next-generation sequencing using a pre-designed gene panel for the molecular diagnosis of congenital disorders in pediatric patients.
Lim EC; Brett M; Lai AH; Lee SP; Tan ES; Jamuar SS; Ng IS; Tan EC
Hum Genomics; 2015 Dec; 9():33. PubMed ID: 26666243
[TBL] [Abstract][Full Text] [Related]
19. Targeted next-generation sequencing helps to decipher the genetic and phenotypic heterogeneity of hypertrophic cardiomyopathy.
Cecconi M; Parodi MI; Formisano F; Spirito P; Autore C; Musumeci MB; Favale S; Forleo C; Rapezzi C; Biagini E; Davì S; Canepa E; Pennese L; Castagnetta M; Degiorgio D; Coviello DA
Int J Mol Med; 2016 Oct; 38(4):1111-24. PubMed ID: 27600940
[TBL] [Abstract][Full Text] [Related]
20. A Next-Generation Sequencing Approach to Identify Gene Mutations in Early- and Late-Onset Hypertrophic Cardiomyopathy Patients of an Italian Cohort.
Rubattu S; Bozzao C; Pennacchini E; Pagannone E; Musumeci BM; Piane M; Germani A; Savio C; Francia P; Volpe M; Autore C; Chessa L
Int J Mol Sci; 2016 Jul; 17(8):. PubMed ID: 27483260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
